<DOC>
	<DOCNO>NCT00461682</DOCNO>
	<brief_summary>SB-705498 demonstrate efficacy several preclinical human experimental pain model . This study investigate efficacy SB-705498 patient rectal pain . This double-blind , placebo-controlled , two-way crossover study . 21 patient faecal urgency ( Group 1 ) , 21 patient IBS ( Group 2 ) complete study .</brief_summary>
	<brief_title>Sb-705498 Rectal Pain Study</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Female/male age 1865 . Women child bear potential must use effective method contraception Faecal urgency define Chan ECG , abnormalities Normal Clinical lab Informed consent understand protocol requirement IBS subject : Has irritable bowel syndrome ( IBS ) define Rome II criterion Rectal hyperalgesia Any clinical biological abnormality find screen ( related disease investigation ) History alcohol , substance drug abuse Uncontrolled hypertension A history presence cardiovascular risk factor Participation trial within 3 month start study History allergy Unable withdraw analgesic medication rectal hyperalgesia ( opioiddependent patient include willing withdraw opiate medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>TRPV1 antagonist</keyword>
	<keyword>Fecal Urgency</keyword>
	<keyword>rectal pain</keyword>
	<keyword>IBS</keyword>
</DOC>